Thank
Growth Stock Picking Strategy: CANSLIM
ChrisWL
liked
Columns How to trade Options
Welcome to Courses in Moo Community, we help you trade like a pro.
540
231
ChrisWL
commented on
NIO Q3 2021 Earnings Conference Call is scheduled on Nov 9 at 8:00 PM ET / Nov 10 at 9:00 am SGT. Subscribe to join the live earnings conference.
Revenue and Net Income
Under the previous Income Statement, NIO's Q2 2021 revenue was RMB 8.45 (USD 1.32) billion, up 127% YoY. The net loss of NIO in Q2 was RMB 587.17 (USD 91.8) million.
In Q3, NIO delivered a total of 24,439 vehicles, a 100.2% YoY increase.
Earnings Preview
The Financial Estimates show that 4 analysts have made an average estimate of RMB 9.32 (USD 1.45) billion in Q3 revenue, a 115 % YoY increase. 3 analysts estimated that NIO's Q2 EPS is RMB -0.587 (USD -0.09).
...
Revenue and Net Income
Under the previous Income Statement, NIO's Q2 2021 revenue was RMB 8.45 (USD 1.32) billion, up 127% YoY. The net loss of NIO in Q2 was RMB 587.17 (USD 91.8) million.
In Q3, NIO delivered a total of 24,439 vehicles, a 100.2% YoY increase.
Earnings Preview
The Financial Estimates show that 4 analysts have made an average estimate of RMB 9.32 (USD 1.45) billion in Q3 revenue, a 115 % YoY increase. 3 analysts estimated that NIO's Q2 EPS is RMB -0.587 (USD -0.09).
...
NIO Q3 2021 Earnings Conference Call
Nov 9 19:00
30
5
ChrisWL
liked
On the last trading day, the NASDAQ Composite index rose0.20%, while the S&P 500 index climbed0.37%, and the Dow Jones Industrial Average added0.56%.
On the last trading day, there was no traditional IPO filed and four new stocks officially listed for trading. Molecular genetics cancer diagnostic company Mainz Biomed surged 99.80% in its trading debut, giving it a market value of $0.12 billion.
Mainz Biomed,formed in 2021,is a molecular genetics cancer diagnostic company to acquire PharmGenomics with the purpose of commercializing its product portfolio in Europe and the US.
PharmGenomics is a manufacturer of in-vitro diagnostic tests with its own molecular genetic laboratory, and has developed several tests for the European market since its 2008 inception.
The company's portfolio consists of ColoAlert, PancAlert, GenoStrip and Legacy Research-Use-Only and IVD tests such as the GenoChips and the HumaSense product line.
Mainz Biomed is commercializing in vitro molecular tests for cancer screening and booked $1 million in revenue for the 12 months ended June 30, 2021.
BriaCell Therapeutics, foudned in , is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors.
Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is focused on conducting Phase I/IIa clinical trial of Bria-IMT in a combination study with immune checkpoint inhibitors.
The Company is also focused on development of Bria-OTS, which is an off-the-shelf personalized immunotherapy based on a patient’s HLA-type. Its other pre- clinical candidates include Bria-Pros, Bria-Lung, Bria-Mel, Bria-TILsRx and others.
As if November 7th, it has a market cap of $0.15 billion, with a listed-to-date return of137.03%.
$Mainz Biomed (MYNZ.US)$ $BriaCell Therapeutics (BCTX.US)$
On the last trading day, there was no traditional IPO filed and four new stocks officially listed for trading. Molecular genetics cancer diagnostic company Mainz Biomed surged 99.80% in its trading debut, giving it a market value of $0.12 billion.
Mainz Biomed,formed in 2021,is a molecular genetics cancer diagnostic company to acquire PharmGenomics with the purpose of commercializing its product portfolio in Europe and the US.
PharmGenomics is a manufacturer of in-vitro diagnostic tests with its own molecular genetic laboratory, and has developed several tests for the European market since its 2008 inception.
The company's portfolio consists of ColoAlert, PancAlert, GenoStrip and Legacy Research-Use-Only and IVD tests such as the GenoChips and the HumaSense product line.
Mainz Biomed is commercializing in vitro molecular tests for cancer screening and booked $1 million in revenue for the 12 months ended June 30, 2021.
BriaCell Therapeutics, foudned in , is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors.
Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is focused on conducting Phase I/IIa clinical trial of Bria-IMT in a combination study with immune checkpoint inhibitors.
The Company is also focused on development of Bria-OTS, which is an off-the-shelf personalized immunotherapy based on a patient’s HLA-type. Its other pre- clinical candidates include Bria-Pros, Bria-Lung, Bria-Mel, Bria-TILsRx and others.
As if November 7th, it has a market cap of $0.15 billion, with a listed-to-date return of137.03%.
$Mainz Biomed (MYNZ.US)$ $BriaCell Therapeutics (BCTX.US)$
+1
5
ChrisWL
reacted to
Top 5 stocks from different platforms is a collection of top trending stocks from major investment platforms and social media, giving investors a list of trending stocks across places.
Moomoo selected the hottest stocks from Robinhood and Investing.com; the most active stocks from Yahoo Finance, Stocktwits, and moomoo; also, the most mentioned stocks across social media platforms captured by SwaggyStocks.
Latest News for Top Stocks:
- $ChargePoint (CHPT.US)$
Moomoo selected the hottest stocks from Robinhood and Investing.com; the most active stocks from Yahoo Finance, Stocktwits, and moomoo; also, the most mentioned stocks across social media platforms captured by SwaggyStocks.
Latest News for Top Stocks:
- $ChargePoint (CHPT.US)$
Expand
31
1
ChrisWL
commented on
Hi, dear moomooers! We are excited to invite you to a special event and claim big rewards.
Before we start, let us you give a "spoiler": There will be 400 winners in total after this event ends. But each day, only the first 40 participants will be eligible to receive our gifts.
So, what are you still waiting for?
How to join this event?
Step 1:Turn on your notification for moomoo app on your phone.
Step 2: Look for the “password”!
Every day, moomoo will send...
Before we start, let us you give a "spoiler": There will be 400 winners in total after this event ends. But each day, only the first 40 participants will be eligible to receive our gifts.
So, what are you still waiting for?
How to join this event?
Step 1:Turn on your notification for moomoo app on your phone.
Step 2: Look for the “password”!
Every day, moomoo will send...
+1
800
601
ChrisWL
liked
There is an eye icon to the left of Net Assets to hide the figures. If you click on it, the figures will be displayed as asterisks. Click on the closed eyelid icon to unhide the figures.
I’m not a staff of Moomoo. I wrote this to help fellow Moomoo users. Pls click below if it has helped you.
Read about my experience with Fullerton Cash Plus SGD https://www.moomoo.com/community/feed/108847657451526?lang_code=2&data_ticket=441896acf760b247a0cf9e113dce06b6&content_type=feeddetail&channel_name=15
I’m not a staff of Moomoo. I wrote this to help fellow Moomoo users. Pls click below if it has helped you.
Read about my experience with Fullerton Cash Plus SGD https://www.moomoo.com/community/feed/108847657451526?lang_code=2&data_ticket=441896acf760b247a0cf9e113dce06b6&content_type=feeddetail&channel_name=15